Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

551 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of once-weekly epoetin beta on survival in patients with metastatic breast cancer receiving anthracycline- and/or taxane-based chemotherapy: results of the Breast Cancer-Anemia and the Value of Erythropoietin (BRAVE) study.
Aapro M, Leonard RC, Barnadas A, Marangolo M, Untch M, Malamos N, Mayordomo J, Reichert D, Pedrini JL, Ukarma L, Scherhag A, Burger HU. Aapro M, et al. J Clin Oncol. 2008 Feb 1;26(4):592-8. doi: 10.1200/JCO.2007.11.5378. J Clin Oncol. 2008. PMID: 18235117 Clinical Trial.
Ondansetron plus dexamethasone is superior to ondansetron alone in the prevention of emesis in chemotherapy-naive and previously treated patients. Swiss Group for Clinical Cancer Research (SAKK).
Joss RA, Bacchi M, Buser K, Kirchner V, Neuenschwander H, Orth B, Aapro MS, Thürlimann B. Joss RA, et al. Among authors: aapro ms. Ann Oncol. 1994 Mar;5(3):253-8. doi: 10.1093/oxfordjournals.annonc.a058803. Ann Oncol. 1994. PMID: 8186174 Free article. Clinical Trial.
Oral ondansetron in the prophylaxis of nausea and vomiting induced by cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in women with breast cancer. Results of a prospective, randomized, double-blind, placebo-controlled study.
Buser KS, Joss RA, Piquet D, Aapro MS, Cavalli F, Haefliger JM, Jungi WF, Bauer J, Obrist R, Brunner KW, et al. Buser KS, et al. Among authors: aapro ms. Ann Oncol. 1993 Jun;4(6):475-9. doi: 10.1093/oxfordjournals.annonc.a058556. Ann Oncol. 1993. PMID: 8353089 Free article. Clinical Trial.
Adjuvant cyclophosphamide, methotrexate, and fluorouracil versus fluorouracil, epirubicin, and cyclophosphamide chemotherapy in premenopausal women with axillary node-positive operable breast cancer: results of a randomized trial. The International Collaborative Cancer Group.
Coombes RC, Bliss JM, Wils J, Morvan F, Espié M, Amadori D, Gambrosier P, Richards M, Aapro M, Villar-Grimalt A, McArdle C, Pérez-López FR, Vassilopoulos P, Ferreira EP, Chilvers CE, Coombes G, Woods EM, Marty M. Coombes RC, et al. Among authors: aapro m. J Clin Oncol. 1996 Jan;14(1):35-45. doi: 10.1200/JCO.1996.14.1.35. J Clin Oncol. 1996. PMID: 8558217 Clinical Trial.
Breast cancer.
Aapro M, Piccart M. Aapro M, et al. Crit Rev Oncol Hematol. 1998 Feb;27(2):135-7. doi: 10.1016/s1040-8428(97)10021-x. Crit Rev Oncol Hematol. 1998. PMID: 9571316 Review. No abstract available.
551 results